Dr. Andrew Arnold, Murray-Heilig Chair in Molecular Medicine, was the featured keynote speaker for the 17th annual John Haddad Memorial Lecture at the University of Pennsylvania’s Perelman School of Medicine on Nov. 6. This endowed lecture honors the memory of the former chief of endocrinology at Penn, and is presented each year by a world-renowned research scientist “who exemplifies the highest ideals of scholarship in the field of bone and mineral metabolism.”
Arnold is a leader in the area of endocrine neoplasia, especially tumors of the parathyroid glands which disrupt the body’s handling of calcium. His Haddad Memorial Lecture was entitled “Primary Hyperparathyroidism: Molecular Insights and Clinical Implications.”
Arnold, professor of medicine and genetics and developmental biology, serves as director of the Center for Molecular Medicine and chief of the Division of Endocrinology and Metabolism at UConn Health. He has received other major awards and recognitions including the Fuller Albright Award and Louis Avioli Founders Award from the American
Society for Bone and Mineral Research; the Gerald Aurbach Award from the Endocrine Society; and is an elected member of the American Society for Clinical Investigation and the Association of American Physicians.